Similar studies by Chandra and Pahan (2018) [97], Chandra et al. (2019) [98], and Luo et al. (2020) [99] found that PPARA activation decreased amyloid plaque pathology and improved memory, supporting the potential of PPARA as an AD therapeutic target. Here, PPARA is linked to Alzheimer disease.